SARTORIUS STEDIM BIOTECH (56S1.DE) Stock Income Statement
FRA:56S1 - Deutsche Boerse Ag - FR0013154002 - Common Stock - Currency: EUR
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.86B | 2.78B | 2.78B | 3.49B | 2.89B | |||
| Minority Interest Expense | -2.30M | -3.40M | -2.40M | -3.80M | 104.00K | |||
| Cost Of Goods | 1.60B | 1.57B | 1.54B | 1.66B | 1.33B | |||
| Gross Profit | 1.25B | 1.21B | 1.23B | 1.83B | 1.55B | |||
| Operating Expenses | 852.80M | 809.00M | 763.20M | 751.80M | 670.02M | |||
| Research and Development | 148.80M | 144.10M | 129.50M | 132.40M | 110.49M | |||
| Selling, General, and Administrative Expenses | 654.50M | 650.50M | 619.50M | 602.60M | 531.60M | |||
| Operating Income | 401.50M | 397.70M | 470.30M | 1.08B | 882.98M | |||
| Interest Income/Expense | -143.90M | -115.40M | -113.40M | -53.00M | 4.06M | |||
| Other Income/Expense | N/A | -20.10M | 59.00M | 147.00M | -213.87M | |||
| Non Recurring Items | N/A | -43.00M | -14.80M | -46.30M | -26.45M | |||
| Income Before Taxes | 257.20M | 219.20M | 401.10M | 1.13B | 646.72M | |||
| Income Tax | 50.60M | 40.70M | 89.00M | 250.50M | 232.41M | |||
| Net Income | 204.30M | 175.10M | 309.70M | 876.10M | 414.41M | |||
| EBITDA | 710.20M | 699.40M | 707.90M | 1.26B | 1.02B | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 2.11 | 1.81 | 3.36 | 9.51 | 4.50 | |||
| Non GAAP EPS | 3.80 | 3.50 | 4.19 | 8.64 | 7.46 | |||
| Statistics | ||||||||
| Gross Profit Margin | 43.89% | 43.41% | 44.44% | 52.52% | 53.79% | |||
| Profit Margin | 7.15% | 6.30% | 11.16% | 25.08% | 14.35% | |||
| Operating Profit Margin | 14.05% | 14.31% | 16.94% | 31.00% | 30.58% | |||
All data in EUR